Subject
*Antithrombins; Female; Fibrinolytic Agents/*therapeutic use; Heparin/*adverse effects; Humans; Middle Aged; Pipecolic Acids/*therapeutic use; Pulmonary Embolism/*chemically induced/*drug therapy; Thrombocytopenia/*chemically induced/*drug therapy; Tissue Plasminogen Activator/*therapeutic use